Clinical Trials on Postnatal Related

Total 51348 results

Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Opioid Addicts - 1

Opioid-Related Disorders

United States
Acura Pharmaceuticals Inc.

Completed

Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Terminated

Pioglitazone to Treat Opioid Withdrawal Symptoms

Opioid-Related Disorders

United States
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)

Completed

Stress and Medication Effects on Cocaine Cue Reactivity

Cocaine Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Johns Hopkins University

Terminated

Abuse Potential of Buprenorphine/Naloxone

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Tramadol to Reduce Opioid Withdrawal Symptoms

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Terminated

Interactions Between Intravenous (IV) Cocaine and Lofexidine

Cocaine Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance Protocol - 1

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Multicenter Clinical Trial of Buprenorphine - 3

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate Day Buprenorphine Administration, Phase XI - 16

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 4 - 4

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Dose Alteration Study - 1

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate Day Buprenorphine Administration, Phase IX - 14

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2

Opioid-Related Disorders

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Long-term Behavior Change - 1

Amphetamine-related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 1 - 1

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1

Opioid-Related Disorders

United States
Indivior Inc.

Completed

Safety and Tolerability of Buprenorphine/Naloxone Film Strips

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification - BBDVI - 19

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Combination Tablet Feasibility - 1

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 18

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase I - 3

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine. Phase V - 6

Opioid-Related Disorders

United States
NYU Langone Health
National Institutes of Health (NIH)

Recruiting

Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder

Problems Related to Social Environment

United States
Chestnut Health Systems

Recruiting

Preventing Parental Opioid and/or Methamphetamine Addiction Within DHS-Involved Families: FAIR (PRE-FAIR)

Opioid-Related Disorders | Mental Health Impairment | Child Neglect | Stimulant-Related Disorder

United States
University of Utah

Completed

Perinatal Care and Medication Assisted Treatment: Carbon/Emery Counties

Pregnancy Related | Opioid-use Disorder

United States
Indiana University
National Institute on Drug Abuse (NIDA)

Recruiting

Maternal Brain Imaging in Opioid Use Disorder

Substance-Related Disorders | Pregnancy Related | Narcotic-Related Disorders | Substance Use | Opioid Use Disorder | Buprenorphine Dependence

United States
Indivior Inc.

Completed

Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED) (OPUS R)

Naloxone | Drug Abuse | Opiate Dependence | Buprenorphine | Opiate-related Disorders
Indivior Inc.

Completed

Open-Label Treatment Extension Study

Opioid Use Disorder | Opioid-related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Effect of Clonidine on Responses to Imagery Scripts

Cocaine Abuse | Heroin Abuse

United States
ER/LA Opioid REMS Program Companies (RPC)

Unknown

Monitoring Patterns of Prescribing to Identify Changes in Access to ER/LA Opioid Analgesics

Drug Abuse | Opiate Addiction | Opioid Related Disorders | Narcotic Abuse
ER/LA Opioid REMS Program Companies (RPC)

Unknown

ER/LA Opioid Analgesics - Surveillance Monitoring of State Medical Examiner Databases

Drug Abuse | Opioid-related Disorders | Narcotic Abuse | Opioid Addiction
Washington University School of Medicine

Recruiting

Improving Health and Employment Outcomes Through Workplace Opioid Policies

Opioid-Related Disorders

United States
Biomedical Development Corporation
National Institute on Drug Abuse (NIDA); The University of Texas Health Science...

Active, not recruiting

Informational App Development for mHealth for Patient Self-Management of Opioid Use Disorder (KIOS-I)

Opioid-Related Disorders

United States
Karlstad Central Hospital

Completed

Intrathecal Morphine for Robotic-assisted Laparoscopic Hysterectomy.

Opioid-Related Disorders

Sweden
Indiana University
National Institute on Drug Abuse (NIDA)

Enrolling by invitation

Fatal Overdose Review Teams - Research to Enhance Surveillance Systems (FORTRESS)

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Maryland, Baltimore

Completed

Youth Opioid Recovery Support: Improving Care Systems (YORS)

Opioid-Related Disorders

United States
Duke University
Alkermes, Inc.; Laura and John Arnold Foundation; FHR (Fellowship Health Resources... and other collaborators

Completed

Feasibility Study of Extended-release Naltrexone (Vivitrol) in Drug Court Settings (DC)

Opioid-Related Disorders

United States
Roxane Laboratories

Completed

Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions

Opioid-Related Disorders

United States
Federal University of São Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Contingency Management Treatment for Crack Addiction - Study With Brazilian Population

Cocaine Related Disorders

Brazil
Medical University of South Carolina
National Institute on Drug Abuse (NIDA); Office of Research on Women's Health...

Completed

The Effect of Yohimbine on Cocaine Cue Reactivity

Cocaine Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Washington D.C. Veterans Affairs Medical Center

Completed

Activity Monitoring Assessment of Opiate Withdrawal - 4

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Washington D.C. Veterans Affairs Medical Center

Completed

Comparison of Buprenorphine and Methadone - 3

Opioid-Related Disorders

United States
University of California, Los Angeles

Completed

Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Britannia Pharmaceuticals Ltd.

Completed

Lofexidine for Opiate Withdrawal - 1

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10

Opioid-Related Disorders

United States

Clinical Trials on Postnatal Related

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations